再拓新领域！新一批医用耗材“团购清单”亮相

Core Viewpoint - The sixth batch of national centralized procurement of high-value medical consumables has been announced, covering 12 types of medical consumables in two categories, with 202 companies and 440 products selected, indicating a diverse range of product options [1] Group 1: Urological Consumables - For the first time, consumables related to urological stone surgery have been included in the centralized procurement, addressing a previous gap in this area [3] - The procurement includes key consumables needed for urological stone surgeries, such as ureteral intervention guidewires and balloon dilation catheters, with 170 companies and 398 products selected, significantly covering the main consumables required for stone surgeries [4] - The inclusion of these consumables is expected to reduce the overall treatment costs for stone diseases, which previously ranged from 20,000 to 30,000 yuan [4] Group 2: Cardiovascular Consumables - The procurement has expanded to include drug-coated balloons, enhancing treatment options for cardiovascular disease patients, complementing previously included stents [5] - A total of 32 companies and 42 products for drug-coated balloons were selected, which are well-matched with clinical usage and are expected to alleviate the financial burden on patients [5] Group 3: Procurement Rules and Impact - The procurement process has been designed to prevent "malicious low pricing" while encouraging technological innovation, ensuring that clinically recognized and capable products are selected [6] - A pricing mechanism has been established to avoid excessively low bids, using 65% of the average price of selected products as a control benchmark [6] - The national medical insurance department has successfully procured 142 types of medical consumables across nine categories, with the implementation of this procurement expected around May 2026 [6]